These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1161972)

  • 1. Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine.
    Sabelli HC; Vazquez AJ; Flavin D
    Psychopharmacologia; 1975 May; 42(2):117-25. PubMed ID: 1161972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of analgesia induced by noncatecholic phenylethylamine derivatives: possible involvement of endogenous opioid peptides and serotonin in phenylethylamine analog-induced analgesia.
    Natsuoka Y; Sakuma M; Uruno T; Kubota K
    Jpn J Pharmacol; 1984 Mar; 34(3):277-87. PubMed ID: 6233440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of β-phenylethylamine and various monomethylated and monohalogenated analogs in mice are mediated by catecholaminergic mechanisms.
    Mosnaim AD; Hudzik T; Wolf ME
    Am J Ther; 2015; 22(6):412-22. PubMed ID: 26544964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of beta-phenylethylamine on photic-evoked potentials in the visual cortex of the cat.
    Taguchi K; Hagiwara Y; Suzuki Y
    Jpn J Pharmacol; 1991 Apr; 55(4):453-9. PubMed ID: 1886290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Phenylethylamine as a possible mediator for delta9-tetrahydrocannabinol-induced stimulation.
    Sabelli HC; Vazquez AJ; Mosnaim AD; Madrid-Pedemonte L
    Nature; 1974 Mar; 248(5444):144-5. PubMed ID: 4274244
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of antinociception induced by noncatecholic phenylethylamine derivatives: the relation of endogenous norepinephrine to phenylethylamine analog-induced antinociception.
    Matsuoka Y; Sakuma M; Sugioka T; Terawaki Y; Uruno T; Kubota K
    Jpn J Pharmacol; 1988 Oct; 48(2):263-72. PubMed ID: 3210449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinol.
    Sabelli HC; Pedemonte WA; Whalley C; Mosnaim AD; Vazquez AJ
    Life Sci; 1974 Jan; 14(1):149-56. PubMed ID: 4810493
    [No Abstract]   [Full Text] [Related]  

  • 10. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
    J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enigma of conditioned taste aversion learning: stimulus properties of 2-phenylethylamine derivatives.
    Greenshaw AJ; Turrkish S; Davis BA
    Physiol Res; 2002; 51 Suppl 1():S13-20. PubMed ID: 12479782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of beta-phenylethylamine on locomotor activity and brain catecholamine metabolism in mice].
    Motohashi N; Nakagawara M; Semba J; Ishii K; Watanabe A; Kariya T
    Yakubutsu Seishin Kodo; 1983 Sep; 3(2):67-75. PubMed ID: 6659713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys.
    Staub RA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1980 Jun; 15(3):429-36. PubMed ID: 6769508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
    Dourish CT
    Br J Pharmacol; 1982 Sep; 77(1):129-39. PubMed ID: 6982090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some further observations of the effect of beta-phenethylamine on locomotor activity in mice.
    Jackson DM
    J Pharm Pharmacol; 1975 Apr; 27(4):278-80. PubMed ID: 239123
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of DOPA on the visual-evoked potentials in rabbit and on mouse motor behavior following inhibition of dopamine-beta-hydroxylase.
    Sabelli HC; Giardina WJ; Myles SB; Vazquez AJ
    Arzneimittelforschung; 1974 Mar; 24(3):333-7. PubMed ID: 4407412
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action.
    Paetsch PR; Greenshaw AJ
    Neurochem Res; 1993 Sep; 18(9):1015-22. PubMed ID: 7901780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of beta-phenylethylamine and related amines on nigrostriatal dopamine neurotransmission.
    Barroso N; Rodriguez M
    Eur J Pharmacol; 1996 Feb; 297(3):195-203. PubMed ID: 8666050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.